2021 annual financial data
Xenon Pharmaceuticals 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -376.97%.
Operating income was -78,993,000 USD and net income was -78,882,000 USD.
Operating cash flow was -69,502,000 USD.
Get free Xenon Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 18,437,000 USD
- Operating income
- -78,993,000 USD
- Net income
- -78,882,000 USD
- Operating cash flow
- -69,502,000 USD